Promoter and Institution shareholding for Coral Laboratories remains unchanged YoY and QoQ, indicating lack of confidence from smart money.

Public shareholding has seen minor increases (+0.21% YoY, +0.03% QoQ), which may reflect a reactive market sentiment rather than proactive investment.

Sector averages show identical trends, suggesting a broader decline in interest across the Pharma sector, aligning with Coral's stagnant performance.